Many risks and unknowns remain about the use of hydroxychloroquine to treat COVID-19. (Courtesy of clevelandclinic.org)
Many risks and unknowns remain about the use of hydroxychloroquine to treat COVID-19. (Courtesy of clevelandclinic.org)

Hydroxychloroquine, the anti-malaria drug that President Trump touted in his use of it last month to help stave off the coronavirus, has proven to be ineffective in fighting the disease, according to a study published in the New England Journal of Medicine.

The study showed that hydroxychloroquine is no more potent in dealing with the novel coronavirus than placebo pills, CBS News reported.

Dr. David Boulware, an infectious disease specialist at the University of Minnesota and the leader of the study, expressed disappointment in the results.

“We would have liked for this to work,” Boulware said, CBS reported. “But our objective was to answer the question and to conduct a high-quality study because the evidence on the drug so far has been inconclusive.”

James Wright Jr.

James Wright Jr. is the D.C. political reporter for the Washington Informer Newspaper. He has worked for the Washington AFRO-American Newspaper as a reporter, city editor and freelance writer and The Washington...

Leave a comment

Your email address will not be published.